BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 33593576)

  • 1. Cationic nanoparticles self-assembled from amphiphilic chitosan derivatives containing poly(amidoamine) dendrons and deoxycholic acid as a vector for co-delivery of doxorubicin and gene.
    Chen S; Deng J; Zhang LM
    Carbohydr Polym; 2021 Apr; 258():117706. PubMed ID: 33593576
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and characterization of amphiphilic glycidol-chitosan-deoxycholic acid nanoparticles as a drug carrier for doxorubicin.
    Zhou H; Yu W; Guo X; Liu X; Li N; Zhang Y; Ma X
    Biomacromolecules; 2010 Dec; 11(12):3480-6. PubMed ID: 21028798
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Carboxymethyl chitosan-poly(amidoamine) dendrimer core-shell nanoparticles for intracellular lysozyme delivery.
    Zhang X; Zhao J; Wen Y; Zhu C; Yang J; Yao F
    Carbohydr Polym; 2013 Nov; 98(2):1326-34. PubMed ID: 24053810
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nanoparticles of deoxycholic acid, polyethylene glycol and folic acid-modified chitosan for targeted delivery of doxorubicin.
    Shi Z; Guo R; Li W; Zhang Y; Xue W; Tang Y; Zhang Y
    J Mater Sci Mater Med; 2014 Mar; 25(3):723-31. PubMed ID: 24327111
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design and evaluation of a novel potential carrier for a hydrophilic antitumor drug: Auricularia auricular polysaccharide-chitosan nanoparticles as a delivery system for doxorubicin hydrochloride.
    Xiong W; Li L; Wang Y; Yu Y; Wang S; Gao Y; Liang Y; Zhang G; Pan W; Yang X
    Int J Pharm; 2016 Sep; 511(1):267-275. PubMed ID: 27424168
    [TBL] [Abstract][Full Text] [Related]  

  • 6.
    Sun R; Fang L; Lv X; Fang J; Wang Y; Chen D; Wang L; Chen J; Qi Y; Tang Z; Zhang J; Tian Y
    Drug Deliv; 2021 Dec; 28(1):2071-2084. PubMed ID: 34595970
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preparation of Cationic Amphiphilic Nanoparticles with Modified Chitosan Derivatives for Doxorubicin Delivery.
    Liu X; Zhou H; Yu W; Xiong X; Krastev R; Ma X
    Materials (Basel); 2021 Nov; 14(22):. PubMed ID: 34832408
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polyamidoamine dendrimer conjugated chitosan nanoparticles for the delivery of methotrexate.
    Leng ZH; Zhuang QF; Li YC; He Z; Chen Z; Huang SP; Jia HY; Zhou JW; Liu Y; Du LB
    Carbohydr Polym; 2013 Oct; 98(1):1173-8. PubMed ID: 23987460
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Co-delivery of cisplatin and doxorubicin by covalently conjugating with polyamidoamine dendrimer for enhanced synergistic cancer therapy.
    Guo XL; Kang XX; Wang YQ; Zhang XJ; Li CJ; Liu Y; Du LB
    Acta Biomater; 2019 Jan; 84():367-377. PubMed ID: 30528609
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro/vivo antitumor study of modified-chitosan/carboxymethyl chitosan "boosted" charge-reversal nanoformulation.
    Li L; Zhang P; Li C; Guo Y; Sun K
    Carbohydr Polym; 2021 Oct; 269():118268. PubMed ID: 34294300
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Label-Free Fluorescent Poly(amidoamine) Dendrimer for Traceable and Controlled Drug Delivery.
    Wang G; Fu L; Walker A; Chen X; Lovejoy DB; Hao M; Lee A; Chung R; Rizos H; Irvine M; Zheng M; Liu X; Lu Y; Shi B
    Biomacromolecules; 2019 May; 20(5):2148-2158. PubMed ID: 30995832
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development and characterization of a new plasmid delivery system based on chitosan-sodium deoxycholate nanoparticles.
    Cadete A; Figueiredo L; Lopes R; Calado CC; Almeida AJ; Gonçalves LM
    Eur J Pharm Sci; 2012 Mar; 45(4):451-8. PubMed ID: 21986445
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Co-delivery nanoparticles with characteristics of intracellular precision release drugs for overcoming multidrug resistance.
    Zhang D; Kong YY; Sun JH; Huo SJ; Zhou M; Gui YL; Mu X; Chen H; Yu SQ; Xu Q
    Int J Nanomedicine; 2017; 12():2081-2108. PubMed ID: 28356731
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chitosan derivatives co-delivering nitric oxide and methicillin for the effective therapy to the methicillin-resistant S. aureus infection.
    Liu S; Cai X; Xue W; Ma D; Zhang W
    Carbohydr Polym; 2020 Apr; 234():115928. PubMed ID: 32070544
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cationic micellar nanoparticles for DNA and doxorubicin co-delivery.
    Lin JT; Zou Y; Wang C; Zhong YC; Zhao Y; Zhu HE; Wang GH; Zhang LM; Zheng XB
    Mater Sci Eng C Mater Biol Appl; 2014 Nov; 44():430-9. PubMed ID: 25280725
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhanced antitumor efficacy of arginine modified amphiphilic nanoparticles co-delivering doxorubicin and iSur-pDNA via the multiple synergistic effect.
    Song Y; Tang C; Yin C
    Biomaterials; 2018 Jan; 150():1-13. PubMed ID: 29028548
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biocompatible cationic pullulan-g-desoxycholic acid-g-PEI micelles used to co-deliver drug and gene for cancer therapy.
    Chen L; Ji F; Bao Y; Xia J; Guo L; Wang J; Li Y
    Mater Sci Eng C Mater Biol Appl; 2017 Jan; 70(Pt 1):418-429. PubMed ID: 27770912
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ternary complex of plasmid DNA electrostatically assembled with polyamidoamine dendrimer and chondroitin sulfate for effective and secure gene delivery.
    Imamura M; Kodama Y; Higuchi N; Kanda K; Nakagawa H; Muro T; Nakamura T; Kitahara T; Sasaki H
    Biol Pharm Bull; 2014; 37(4):552-9. PubMed ID: 24694603
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preparation, characterization and transfection efficiency of cationic PEGylated PLA nanoparticles as gene delivery systems.
    Chen J; Tian B; Yin X; Zhang Y; Hu D; Hu Z; Liu M; Pan Y; Zhao J; Li H; Hou C; Wang J; Zhang Y
    J Biotechnol; 2007 Jun; 130(2):107-13. PubMed ID: 17467097
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel hyaluronic acid coated hydrophobically modified chitosan polyelectrolyte complex for the delivery of doxorubicin.
    Chen L; Zheng Y; Feng L; Liu Z; Guo R; Zhang Y
    Int J Biol Macromol; 2019 Apr; 126():254-261. PubMed ID: 30584933
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.